Shared decision-making aid for juvenile idiopathic arthritis: moving from informative patient education to interactive critical thinking
To develop and evaluate an illustrated, stand-alone, interactive evidence-based shared decision making (SDM) aid for JIA children; its ability to produce positive perceived involvement of JIA patients in their own management and its impact on their adherence to therapy, school absenteeism and treatment outcomes.
The SDM aid was developed to offer information about the disease, risks and benefits of treatment. A multidisciplinary team defined SDM criteria based on international standards (IPDAS). Eight categories emerged as highly important for SDM. Each category was supported by simple illustrations in an interactive style. At the end of each category, the child is asked to make a decision in view of the information given. Ninety-four JIA children were provided with the tool, in a randomised controlled study, in comparison to a control group of 95 JIA patients treated according to standard protocols.
A total of 97.5% of the study children reported comprehensibility of more than 90%. The patients’ adherence to therapy was significantly (p < 0.01) higher in the SDM group, whereas stopping DMARDs for intolerability was significantly higher in the control group at 12 months of treatment. There was a significant improvement in the patient-reported outcomes in the SDM group, and absence from school was significantly higher in the control group (p < 0.01).
• This work represents the second generation of shared decision-making tools.
• The developed tool adopts an interactive style and enhances critical thinking, giving the patients the facility of making their own decision regarding their management.
• The work gives an example of core domain set of outcomes which can be used for shared decision-making interventions.
KeywordsAdherence Arthritis Interactive thinking JIA Shared decision making
We express thanks to all participants, our colleagues, research assistants and nurses for their cooperation and help to bring this research to its final conclusions. Special thanks to Mr. Ali El Miedany (DGS-Dartford, England) for his contribution to the illustration choices and data entry.
All authors contributed in the study methodology, analysis and interpretation of the data and outcomes as well as the manuscript writing, reading and approval of the final version. Prof. Wassif shared in the illustrations selection process and visual aids development. Prof. El Gaafary carried out statistical analysis and reviewed the methodology and results sections. Y. El Miedany developed the figures.
Compliance with ethical standards
- 1.El Miedany Y (2014) Adopting patient-centered care in standard practice: PROMs moving toward disease-specific era. Cin Exp Rheumatol 32(Suppl 85):S40–S46Google Scholar
- 2.NICE. Shared decision making. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines/shared-decision-making. Accessed on 20 June 2018
- 3.El Miedany Y, El Gaafary M, Sayed S, Palmer D, Ahmed I (2016) Implementing shared decision making in clinical practice: outcomes of a new shared decision making aid for chronic inflammatory arthritis patients. J Pat Care 2:2Google Scholar
- 7.Lipstein EA, Lovell DJ, Denson LA, Moser DW, Saeed SA, Dodds CM, Britto MT (2012) Parents’ information needs in tumor necrosis factor-alpha inhibitor treatment decisions. J Pediatr Gastroenterol Nutr 65:244–250Google Scholar
- 12.Arthritis Research UK. https://www.arthritisresearchuk.org/system/search-results.aspx?keywords=JIA. Accessed on 20 June 2018
- 13.West Michigan Rheumatology PLLC. Patient Decision Aids. http://www.mi-arthritis.com/patient-decision-aids/. Accessed 20 June 2018
- 14.DeWitt EM, Lipstein EA, Staun K, Scherer L, Taylor J, Lannon CM, Brinkman W (2014) A178: development of tools to facilitate shared decision making about medications for juvenile idiopathic arthritis—a project of the pediatric rheumatology care and outcomes improvement network. Arthritis Rheumatol 66(S3):S232–S233CrossRefGoogle Scholar
- 18.International Patient Decision Aid Standards Collaboration 2006: Checklist for Judging the Quality of Patient Decision Aids. http://ipdas.ohri.ca/IPDAS_checklist.pdf website. Accessed 20 June 2018
- 19.Elwyn G, O’Connor A, Stacey D, Volk R, Edwards A, Coulter A et al (2006) International patient decision aids standards (IPDAS) collaboration: developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 333:417–423CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M (2011) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 10:Art. No.:CD001431Google Scholar
- 21.Ottawa Personal Decision Guide, 2-page interactive PDF. http://decisionaid.ohri.ca/decguide.html website. Accessed 20 June 2018
- 26.Hertzog M (2008) Considerations in determining sample size for pilot studies. Res Nurs Heatlh 31:180–191Google Scholar
- 27.El Miedany Y, Lotfy H, El Aroussy N, Mekkawy D, Nasef SI, Hassan W, El Deriny G, Farag Y, Eissa M, Almedany S, El Gaafary M, on behalf of PRINTO Egypt (2018) Facilitating patient centred care: the development of illustrated multidimensional patient reported outcome measure for children with juvenile idiopathic arthritis. Ann Rheum Dis 77:502Google Scholar
- 28.Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A, Paediatric Rheumatology International Trials Organisation (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Care Res 61:658–666CrossRefGoogle Scholar
- 30.Wallace CA, Ruperto N, Giannini E (2004) Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 3:22904Google Scholar
- 38.SPSS Inc Released 2007. SPSS for windows, version 16.0. Chicago, SPSS IncGoogle Scholar
- 39.Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB et al (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 1:CD001431Google Scholar
- 41.O'Connor A, Llewwllyn-Thomas H, Flood A (2004) Modifying unwarranted variations in health care: shared decision making using patient decision aids. Health Aff (Millwood). Suppl Variation:VAR63-VAR72. https://www.ncbi.nlm.nih.gov/pubmed/15471770?dopt=Citation. Accessed 20 June 2018
- 45.Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JWJ, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JMW, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PLCM, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73:492–509CrossRefGoogle Scholar
- 47.Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landewé R, Oliver S, Aletaha D, Betteridge N, Braun J, Burmester G, Cañete JD, Damjanov N, FitzGerald O, Haglund E, Helliwell P, Kvien TK, Lories R, Luger T, Maccarone M, Marzo-Ortega H, McGonagle D, McInnes IB, Olivieri I, Pavelka K, Schett G, Sieper J, van den Bosch F, Veale DJ, Wollenhaupt J, Zink A, van der Heijde D (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75:499–510CrossRefPubMedGoogle Scholar
- 48.National assessment of adult learning (NAAL) demographics. https://nces.ed.gov/NAAL/kf_demographics.asp. Accessed 20 June 2018